Obagi Medical Products (OMPI) announced Tuesday morning that it received a takeover offer from Merz Pharma Group for $22 per share in cash. On March 20, 2013, Obagi announced that it entered into a definitive merger agreement with Valeant Pharmaceuticals International (VRX).
Obagi Medical Products gapped open sharply higher Tuesday, but moved in a narrow range throughout the session. Shares finished up by 3.17 at $22.88 on above average volume. The stock surged past a week and a half long range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.